DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
|
DGAP-News: EVOTEC SE
/ Key word(s): Miscellaneous
Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance 06.07.2022 / 07:30 The issuer is solely responsible for the content of this... |